Anargyros Skoulakis

Anargyros Skoulakis

Auto-generated profile, based on publicly available information

Anargyros Skoulakis

University of Thessaly DIANA-Lab, Department of Computer Science and Biomedical Informatics Lamia , 35131

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
ASAnargyros Skoulakis
Anargyros Skoulakis
VKVasiliki Kostoula
Vasiliki Kostoula
KDKonstantinos Daniilidis
Konstantinos Daniilidis
CGChristos-Georgios Gkountinoudis
Christos-Georgios Gkountinoudis
EPEfthymia Petinaki
Efthymia Petinaki
Artemis G. HatzigeorgiouArtemis G. Hatzigeorgiou
Artemis G. Hatzigeorgiou
Antimicrobial resistance (AMR) remains a critical challenge in public health and research. AmrProfiler is a comprehensive tool with three specialized modules: identifying acquired AMR genes, resistance-associated mutations, and ribosomal RNA (rRNA) gene mutations across nearly 18 000 bacterial species. By integrating and refining data from established databases, it provides a robust framework for AMR analysis. AmrProfiler is the first to systematically report mutations in rRNA genes, offering in-depth analysis of rRNA copy numbers and mutations—key for identifying potential rRNA-associated resistance mechanisms. Its curated database includes 7600 unique AMR gene entries and over 4300 resistance-related mutations. Supporting genome assemblies in multiple formats, AmrProfiler allows users to customize detection thresholds for AMR genes, mutations, and rRNA analysis. Validation with Acinetobacter baumannii,Escherichia coli,Klebsiella pneumoniae,Staphylococcus aureus, and Staphylococcus epidermidis demonstrated that AmrProfiler accurately identified all AMR genes and mutations reported by other tools while also detecting additional resistance markers and mutations not previously recognized. By bridging AMR genotypes and phenotypes, AmrProfiler provides actionable insights that advance both research and clinical applications in AMR. AmrProfiler is freely available as an open-access web server without login at https://dianalab.e-ce.uth.gr/amrprofiler.

25 July 2025 in bioRxiv
Verified
Preprint
Open access
ASAlexandros Simistiras
Alexandros Simistiras
OBOzvan Bocher
Ozvan Bocher
CEChristina Emmanouil
Christina Emmanouil
ASAnargyros Skoulakis
Anargyros Skoulakis
SGStavros Glentis
Stavros Glentis
ADAntigone S Dimas
Antigone S Dimas
The effect of diet on genetic regulation in humans remains largely unexplored. Here, we investigated gene-by-diet interactions in a unique group of apparently healthy individuals (N=200) who alternate between omnivory and dietary restriction of animal products for religious reasons. Using longitudinal plasma proteomic and genotypic data, we identified diet-responsive cis-protein quantitative trait loci (cis-pQTLs) including gain of genetic regulatory effects for LBR and MSRA, proteins linked to cholesterol and methionine metabolism respectively. LBR-associated diet-responsive cis-pQTL rs74148404 showed suggestive evidence of colocalization with obesity exclusively under dietary restriction, suggesting diet-dependent differential genetic risk for disease. Additionally, a novel dietary restriction-associated cis-pQTL for metabolic regulator FGF21 colocalized with eosinophil and platelet traits pointing to diet-sensitive immunometabolic signalling. By parallel profiling of a continuously omnivorous control group (N=211), we also uncovered seasonally dynamic gain and loss of genetic regulation for proteins linked to apoptosis in immune system pathways (MAVS, CASP3, PDLIM7 IL12RB1), effects likely masked by animal product restriction. These findings reveal dynamic diet- and season-sensitive regulatory mechanisms with implications for precision nutrition and individualized disease prevention strategies, and underscore the need to integrate environmental context into genetic studies of health and disease.